BI-D1870
- Katalog-Nr.:A871649
- CAS-Nr. : 501437-28-1
- Molekularformel:C19H23F2N5O2
- Molekulargewicht: 391.42
Hinweis*
1. Please click the to confirm the discount and stock quantity.
2. Click“Bulk Inquiry”to ask for quotations of other quantity.
3. The price does not include shipping and bank charges.
Massenanfrage
1. Please click the to confirm the discount and stock quantity.
2. Click“Bulk Inquiry”to ask for quotations of other quantity.
3. The price does not include shipping and bank charges.
Produktdetails
CAS-Nummer | 501437-28-1 | Aussehen | Off-White powder |
Katalognummer | A871649 | MDL-Nummer | MFCD11223662 |
Molekularformel | C19H23F2N5O2 | Molekulargewicht | 391.42 |
Siedepunkt | 579.3°C at 760 mmHg | Schmelzpunkt | |
Flammpunkt | Dichte | ||
Synonyme | 2-((3,5-Difluoro-4-hydroxyphenyl)amino)-8-isopentyl-5,7-dimethyl-7,8-dihydropteridin-6(5H)-one | ||
Lagerungszustand | Store in a tightly closed container,in a cool and dry place |
Sicherheit
GHS-Piktogramm | |||
Signalwort | Warning | UN-Nummer | |
Gefahrenhinweise | H302-H315-H319-H335 | Klasse | |
Sicherheitshinweise | P261-P305+P351+P338 | Verpackungsgruppe |
Beschreibung
FIPI is a potent and selective phospholipase D inhibitor. FIPI attenuate mercury-induced lipid signaling leading to protection against cytotoxicity in aortic endothelial cells. FIPI rapidly blocks in vivo PA production with subnanomolar potency. We were surprised to find that several biological processes blocked by 1-butanol are not affected by FIPI, suggesting the need for re-evaluation of proposed FIPI does inhibit PLD regulation of F-actin cytoskeleton reorganization, cell spreading, and chemotaxis, indicating potential utility for it as a therapeutic for autoimmunity and cancer metastasis. |